Capricor Therapeutics, Inc. , a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced that it has been approved to begin trading its common stock on the NASDAQ Capital Market. Capricor's common stock will begin trading under the same symbol, CAPR, at the opening of market hours on Monday, March 9, 2015.
http://ift.tt/1BbvLbH
http://ift.tt/1BbvLbH
No comments:
Post a Comment